Bone Marrow TransplantationAnemia, AplasticTransplantation, HomologousGraft vs Host DiseaseBone MarrowWhole-Body IrradiationBone Marrow CellsLeukemiaTransplantation ConditioningTransplantation, AutologousTransplantation ChimeraBusulfanTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalHistocompatibility TestingHematopoietic Stem Cell TransplantationLeukocyte TransfusionRecurrenceAnemiaGraft vs Tumor EffectHistocompatibilityGraft vs Host ReactionCyclophosphamideImmunosuppressive AgentsLeukemia, Myeloid, AcuteRadiation ChimeraPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionHematologic NeoplasmsLymphocyte DepletionAntilymphocyte SerumGraft vs Leukemia EffectTransplantation, IsogeneicAcute DiseaseImmunosuppressionMyelodysplastic SyndromesBone and BonesCyclosporineLeukemia, MyeloidHematopoietic Stem CellsLymphocyte TransfusionHepatic Veno-Occlusive DiseaseBone Marrow PurgingHematopoiesisCombined Modality TherapyMice, Inbred C57BLT-LymphocytesTreatment OutcomeChimeraPancytopeniaTime FactorsGraft RejectionLiver TransplantationNuclear FamilyHLA AntigensSurvival AnalysisTransplantation ImmunologyHematologic DiseasesActuarial AnalysisRetrospective StudiesBone Marrow DiseasesFatal OutcomeCytomegalovirus InfectionsMice, Inbred BALB CLymphoma, Non-HodgkinSurvival RateSevere Combined ImmunodeficiencyFollow-Up StudiesAnemia, Refractory, with Excess of BlastsGranulocyte Colony-Stimulating FactorLeukocyte CountCytarabineAnemia, RefractoryKidney TransplantationDisease-Free SurvivalAntineoplastic Combined Chemotherapy ProtocolsFanconi AnemiaBone Marrow ExaminationSpleenInfectionBlood TransfusionColony-Forming Units AssayStem Cell TransplantationLeukemia, Myelomonocytic, AcuteMethotrexateCyclosporinsImmunocompromised HostLymphomaEtoposidePrognosisCytogeneticsFlow CytometryNeoplasm, ResidualLife TablesMultiple MyelomaHemoglobinuria, ParoxysmalGanciclovirSalvage TherapyBone Remodeling